Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.

Let’s Stay In Touch

Shopping cart

Subtotal $0.00

View cartCheckout

Comprehensive Treatment Plan for Early-Stage Neuroendocrine Tumors (NETs) (Stage 1 & 2)

  • Home
  • Comprehensive Treatment Plan for Early-Stage Neuroendocrine Tumors (NETs) (Stage 1 & 2)

Neuroendocrine tumors (NETs) are rare tumors that develop in neuroendocrine cells, commonly found in the pancreas, intestines, lungs, or stomach. When diagnosed early, NETs have a high treatment success rate, often exceeding 90% with proper surgical and targeted therapies.

Germany is a global leader in neuroendocrine tumor treatment, offering:

✅ Advanced PET-CT & Gallium-68 DOTATATE scans for precise tumor localization

✅ Minimally invasive & robotic-assisted surgery for organ preservation

✅ Peptide Receptor Radionuclide Therapy (PRRT) for NETs expressing somatostatin receptors

✅ Comprehensive long-term follow-up and tumor marker monitoring

At WEGOVITA, we coordinate access to Germany’s leading NET specialists, hospitals, and innovative treatments to ensure the best possible outcome.

Phase 1: Pre-Arrival Services (Before Coming to Germany)

WEGOVITA assists in:

Initial consultation with Germany’s top NET specialists via video call.
Review of previous imaging scans, biopsy results, tumor markers, and medical history.
Personalized treatment recommendations & cost estimates.
Visa assistance, accommodation arrangements, and airport-hospital transfers.
Translation of medical documents (if required).

Estimated Cost: €1,500 – €3,000 (depending on additional services).

Phase 2: Initial Examination & Diagnostic Workup (Upon Arrival in Germany)

Step 1: Initial Medical Consultation & Physical Examination:
  • Comprehensive medical assessment & review of symptoms.
  • Evaluation of hormone secretion status (if functioning NET is suspected).
Step 2: Blood Tests & Tumor Markers
  • Chromogranin A (CgA), 5-HIAA (for serotonin-secreting tumors).
  • Somatostatin receptor expression testing for PRRT eligibility.
Step 3: Imaging & Staging of Disease
  • Gallium-68 DOTATATE PET-CT Scan – Gold standard for NET detection and staging.
  • MRI & CT Scan (Abdomen & Pelvis) – For additional tumor assessment.
  • Endoscopic Ultrasound (EUS) (for pancreatic NETs) – To evaluate tumor depth.

Estimated Cost for Diagnostics: €6,000 – €10,000

Phase 3: Surgical Treatment – Minimally Invasive Resection of Tumor

Step 4: Surgery – Laparoscopic or Robotic-Assisted Colorectal Resection

Definition: A minimally invasive surgical approach to remove localized neuroendocrine tumors while preserving healthy tissue and organ function.

Surgical Options:

✅ Enucleation – Removal of the tumor without removing the entire organ (for small pancreatic NETs).

✅ Laparoscopic Partial Resection – Removes affected tissue while preserving digestive function.

✅ Robotic-Assisted Surgery – Enhances precision for complex cases.

Ideal for:

✅ Stage 1 & 2 NETs localized in the pancreas, intestines, or stomach.

✅ Functioning NETs that cause hormone-related symptoms.

Estimated Cost for Surgery: €30,000 – €60,000

Phase 4: Post-Surgery Hospital Stay & Recovery

Step 5: Hospital Stay & Post-Operative Monitoring

✅ Duration: 5-10 days in a specialized surgical center.

✅ 24/7 monitoring, pain management, and post-surgical care.

✅ Nutritional support & hormone level monitoring post-surgery.

Step 6: Preventive Measures & Early Detection of Recurrence

✅ Final histopathology report on tumor removal.

✅ Follow-up PET-CT scan to confirm complete tumor resection.

✅ Endocrinologist consultation if hormone imbalances occur post-surgery.

Estimated Cost for Hospitalization & Post-Surgical Care: €8,000 – €15,000

Phase 5: Targeted Therapy & Advanced Treatment Options (If Needed)

️ Step 7: Peptide Receptor Radionuclide Therapy (PRRT) for High-Risk NETs

✅ PRRT is a nuclear medicine therapy that delivers radiation directly to NETs expressing somatostatin receptors.

✅ Indicated for Stage 2 NETs with high recurrence risk or inoperable cases.

Estimated Cost for PRRT Treatment (if needed): €40,000 – €70,000

Phase 6: Follow-Up & Post-Treatment Care Plan

Step 8: Comprehensive Follow-Up Plan (6-12 Months Post-Surgery)

✅ Routine oncological check-ups every 3-6 months for the first 2 years.

✅ Chromogranin A & 5-HIAA testing for tumor recurrence monitoring.

✅ Gallium-68 PET-CT scan once a year (if required).

Step 8: Comprehensive Follow-Up Plan (6-12 Months Post-Surgery)

✅ Virtual consultations with German NET specialists.

✅ Personalized dietary and hormone management plans.

✅ Second opinion access for additional therapies if needed.

✅ Emergency medical coordination & ongoing monitoring.

Estimated Cost for Follow-Up Plan (1 Year): €5,000 – €10,000

Total Estimated Cost for Neuroendocrine Tumor Treatment

Phase Services Provided Estimated Cost (€)
Pre-Arrival Services Virtual consultation, visa assistance, document translation €1,500 – €3,000
Diagnostics & Staging Blood tests, Gallium-68 PET-CT, MRI, endoscopic imaging €6,000 – €10,000
Surgical Treatment Laparoscopic or robotic-assisted NET resection €30,000 – €60,000
Hospital Stay & Recovery 5-10 days in hospital, post-operative care €8,000 – €15,000
Advanced Therapy (If Needed) Peptide Receptor Radionuclide Therapy (PRRT) €40,000 – €70,000
Follow-Up Plan (1 Year) Oncological check-ups, imaging, WEGOVITA aftercare €1,000 – €5,000
Total Estimated CostComprehensive treatment & care package €49,500 – €163,000

📍 Why Choose WEGOVITA for Your Treatment?

💎 We connect you with Germany’s leading NET specialists & hospitals.

💎 State-of-the-art diagnostics with Gallium-68 PET-CT imaging.

💎 Access to minimally invasive & robotic-assisted surgeries.

💎 Personalized support before, during, and after treatment.

📩

Request Now – Receive expert evaluation from top German doctors in 48 hours and start your treatment journey in just 3 weeks!
 

💡Important for You

WEGOVITA offers medical coordination services by connecting international patients with top hospitals and specialists across Germany. We support access to expert evaluations, facilitate treatment logistics, and present a range of available medical options.

However, WEGOVITA does not provide direct medical treatment, make medical diagnoses, or recommend specific therapies. All final medical decisions—including diagnosis, treatment planning, and cost—are made solely by licensed medical professionals after a full clinical assessment of the individual patient.

This information is provided for informational purposes, based on internationally recognized guidelines and practices used in Germany’s leading medical institutions. It is not a substitute for professional medical advice.

💡 Interested in clinical trial references, treatment innovations, or cost comparisons? Contact our medical coordination team at info@wegovita.com for personalized assistance.

Your Health. Your Journey. With WEGOVITA.